KeraVet Bio

📍 Winston Salem, United States🗓 Founded 2022👥 9 employees💰 Last funded Jun 2023
Biotechnology Research🌐 keravetbio.com
Website LinkedIn
At KeraVet® Bio we love our pets, which is why we have created KeraVet Gel to revolutionize animal wound care. KeraVet Gel is a reformulation of an FDA-cleared product used in human clinics called KeraStat® Gel and is based on our leading science and patent-protected technology. KeraVet Gel is indicated for managing common wounds in dogs and cats, including hotspots, lick granulomas, and surgical incisions. KeraVet Gel is applied topically and is designed to lessen healing time and reduce or eliminate the need to keep your pet in an e-collar. The team at KeraVet Bio has decades of experience in medical research and commercialization of wound and regenerative medicine products. From medicine to consumer healthcare, our team brings a wealth of knowledge and experience in creating, testing, and manufacturing FDA-regulated products.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in KeraVet Bio?
KeraVet Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did KeraVet Bio last raise funding?
The most recent investment in KeraVet Bio recorded on gritt.io was in June 2023.
When was KeraVet Bio founded?
KeraVet Bio was founded in 2022.
What industry is KeraVet Bio in?
KeraVet Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is KeraVet Bio based?
KeraVet Bio is headquartered in Winston Salem, United States.